epatitis C virus is the most common cause of chronic hepatitis in the United States. 1 In patients with chronic HCV infection, assessments of the severity of inflammatory liver injury (grade) and the degree of hepatic scarring (stage) are used to guide clinical management. 2 Gray scale ultrasonography has been reported to detect histologic features of chronic liver disease. [3] [4] [5] [6] [7] [8] [9] [10] We compared retrospectively the gray scale liver images and histologic results in hepatitis C patients evaluated with sonographically guided liver biopsy to see if any correlation existed between sonographic and biopsy findings. If a positive correlation did exist, ultrasonography could be an important costeffective means of monitoring the disease in these patients.
MATERIALS AND METHODS
Over a four year period (1993) (1994) (1995) (1996) , 77 patients with chronic HCV infection and a positive anti-HCV antibody test (ELISA-2, Ortho-Diagnostics, Raritan, NJ) underwent percutaneous ultrasonographically Gray scale ultrasonographic images of the liver were correlated with histologic findings in patients with chronic hepatitis C virus infection. The gray scale patterns of 64 livers with chronic hepatitis C virus infection were categorized as normal, fatty, fibrofatty, fibrotic, or inflammatory and were graded as mild, moderate, or severe. Liver biopsy specimens also were analyzed for the presence of fat, inflammation, and fibrosis and graded similarly. No correlation was found between fatty and fibrofatty sonographic findings with any of the three histologic patterns. Correlations were found between fibrotic sonographic findings and both fibrotic and inflammatory histologic findings (r = 0.27; P = 0.03). Although some pathologic features of liver disease were detected by ultrasonography, no useful correlation was noted between results of sonography and histologic examination. KEY WORDS: Hepatitis C virus; Liver, ultrasonography; Infection, hepatitic C.
guided liver biopsy at our institution. Sixty-four of these patients formed our study population. Ultrasonograms, liver biopsy results, and clinical information were available for this group. All images of the liver were acquired with Acuson XP 10 and 128 units (Acuson, Mountain View, CA) using V4, V328, V3.5, or C366 transducers. Two or three core liver biopsies were obtained from the anterior segment of the right lobe in each patient using an 18 gauge needle (Bard Biopty or Magnum assembly, C.R. Bard, Covington, GA). Patient age, sex, serum ALT level, sonographic size and texture of the liver, and liver histologic findings were reviewed. Size was determined by standard measurement of cranial to caudal length in the right midaxillary line.
Sonographic images were classified simultaneously by two blinded readers (R.K., G.S.) as having normal, fatty, fibrofatty, fibrotic, or inflammatory patterns. A liver was considered fatty if it demonstrated increased echogenicity, loss of portal venule walls, closely packed echoes, and decreased through-transmission. A liver was considered fibrotic if it demonstrated a coarsened echotexture with a pinhead pattern but with preservation of the diaphragm. A fibrofatty liver had both fibrotic and fatty features. A liver was considered inflammatory if echogenic portal triads were observed in a hypoechoic liver or preservation of portal triads was noted in a background of fatty infiltration. 5, 8 If any features of cirrhosis were present, including an irregular contour or nodularity, the liver disease was graded as severe (3) fibrosis. Grading was otherwise done subjectively for degree of severity of the various ultrasonographic patterns. After the images of the liver were categorized appropriately on the basis of the sonographic pattern, the images within the given category were then graded subjectively on a spectrum as mild (1), moderate (2), or severe (3).
Biopsy specimens were examined blindly for the presence or absence of steatosis, inflammation, and fibrosis and were graded using the method of Desmet and coworkers. 11 Statistical comparison of sonographic patterns with corresponding histologic findings was performed using a Spearman rank correlation coefficient.
Results from a subset of 35 patients with endstage renal disease or a history of end-stage renal disease and a functioning renal allograft were analyzed separately by a Wilcoxon rank sum test for differences in sonographic and histologic findings. Because biopsy specimens from 12 of these patients were examined by two pathologists (F.S., S.N.T.) separately, the histologic results from these specimens were analyzed for correlation by an intraclass correlation coefficient.
RESULTS
Clinical evaluations, sonograms, and liver biopsy specimens from 64 patients (39 male, 25 female) aged 17 to 67 years (mean, 43.9 ± 11.6 SD; median, 44 years) were analyzed (Figs. 1 to 3 ). Liver size was 12 to 20.2 cm (mean, 15.2 cm ± 2 SD). ALT values were one to 68 times the ULN (which equaled 40 units) with a mean of 2.9 times the ULN and a median of one times the ULN (54.8%). Thirty-five patients had end-stage renal disease, four had a history of alcohol abuse, two had biopsy-proved cirrhosis, and one had congestive heart failure. Two patients had ascites; Correlation was found between abnormal serum levels and histologic inflammation (r = 0.3, P < 0.01) in study patients. Ultrasonographic and histologic findings are presented in Table 1 . Note that no sonographic categories were considered inflammatory. No correlation was found between the fatty or fibrofatty patterns on ultrasonography and the histologic findings of steatosis, fibrosis, or inflammation. However, a correlation was found between the fibrotic pattern on ultrasonography and the presence of fibrosis and inflammation at histologic examination (r = 0.27, P = 0.03). In addition, no correlation was noted between grade of fibrosis on ultrasonography and grade of fibrosis on histologic examination. An inverse correlation was observed between increasing liver size and fibrotic pattern on ultrasonography (r = 0.33, P < 0.01). This is expected since the liver shrinks as it becomes increasingly fibrotic or cirrhotic. A similar correlation could not be made between liver size and the presence of fibrosis at histologic examination. The reason for this lack of correlation remains unclear, but it may be due to sampling error. In the subset of 35 patients with endstage renal disease, no additional correlation between sonographic findings and histologic findings was present. In the group of 12 patients in whom the biopsy specimens were examined by two pathologists separately, poor interobserver correlation was noted in grading of inflammation and fibrosis (Table 2) .
DISCUSSION
The degree and type of liver injury in patients with acute or chronic liver disease has been difficult to evaluate using ultrasonography, although gray scale criteria for the diagnosis of hepatic inflammation, scarring, and fatty infiltration have been established. We used these criteria in our analysis of sonograms in patients with chronic HCV infection, 3-10 as described in the Materials and Methods section. The difference between fatty, fibrofatty, and fibrotic patterns often was difficult to perceive sonographically. Similarly, the severity of the patterns occurred over a continuous spectrum and was difficult to grade. The ultrasonongraphic pattern of inflammation is the most difficult to perceive, and none of the gray scale images in our series demonstrated either a hypoechoic liver or preserved portal triads. 4, 9 Although these variable gray scale patterns have been described to be typical of fat, fibrosis, and inflammation, this study suggests that these diagnoses are not entirely accurate in patients with chronic HCV infection. When a gray scale sonographic diagnosis of a fibrofatty or fatty liver was made, for example, fat or fibrosis was not necessarily present histologically, and often associated inflammatory changes were present that were not detected at all by ultrasonography. No patient had an inflammatory component on ultrasonography, although 56 patients had this clinically important finding on biopsy. Equally disturbing was the correlation between fibrosis on sonography and the presence of histologic inflammation. Fibrosis is usually a permanent change, whereas inflammation implies an active 
A B
but potentially reversible process that may resolve without leaving any residual structural abnormality. Two limitations of this study are that it was a retrospective study, and prospective liver evaluation during scanning would likely allow for more accurate parenchymal analysis. Over the 4 year period of data accumulation, equipment and transducers improved, with superior imaging of the liver being possible in the more recent cases.
Nevertheless, this study demonstrates that, at the present time, gray scale ultrasonography cannot be used as a method of grading or staging chronic HCV infection, and, by inference, other inflammatory liver diseases with the same histologic abnormalities. Appropriate management of HCV infection requires accurate grading and staging; chronic inflammation with only minimal fibrosis and small amounts of hepatic iron favors a good response to therapy with alpha-interferon 2. Biopsy is equally important in the care of patients with other inflammatory liver diseases, many of which cannot be diagnosed accurately without examination of a liver biopsy specimen.
A correlation was found between elevated serum ALT levels and the presence of inflammation on histologic examination. This finding is consistent with the results of other studies, although it is considered to be unreliable by hepatologists, as active disease can be found in patients with low or normal ALT levels.
It is widely recognized that some variation will occur in interpretation of liver biopsy findings from observer to observer. This was certainly demonstrated in the 12 biopsy specimens that were evaluated by the two pathologists in our study (Table 2) . A sampling error of up to 10% is accepted for liver biopsies in some diseases. 4 This fact and the findings in our study do raise some concern regarding use of pathologic findings as the gold standard.
Since a large portion of our study population had end-stage renal disease, we examined this group as a subset to determine if they had any unique characteristics. Previous studies have shown that HCV infection is not made worse by hemodialyisis or renal transplantation and associated immunosuppression. 10 Findings in the subset of patients with end-stage renal disease evaluated in our study were not different from those in the rest of the study population. Slightly more fat was detected by ultrasonography and biopsy in these patients, a finding that might be related to chronic immunosuppressive therapy with prednisone. (1-4-0) (3-1-0) Fibrofatty (16) 2 10 14 13 (6-2-2) (7-6-1) (8-3-2) Fibrotic (28) 3 13 25 21 (10-3-0) (9-10-6) (7-7-7)
In conclusion, although microscopic features of liver disease in patients with chronic HCV infection were detected by ultrasonography, no consistent correlation between sonographic and histologic findings was found, suggesting that ultrasonographic imaging is unreliable for grading and staging the degree of liver damage in chronic HCV infection.
